Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 31973566 | HLA-CLASS I (HLA CLASS II) | migraine | NA | NA | NA | positive | |
| hla class i alleles are associated with clinic-based migraine and increased risks of chronic migraine and medication overuse. | |||||||
| 31973566 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | migraine | NA | NA | NA | unclassified | |
| we utilized likelihood ratio tests to examine human leukocyte antigen-disease associations and logistic regressions to estimate the effect of human leukocyte antigen alleles on migraine. | |||||||
| 31973566 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | migraine | NA | NA | NA | positive | |
| human leukocyte antigen-b and c showed significant associations with clinic-based migraine (q-value < 0.05). | |||||||
| 31973566 | HLA-B*58 | migraine | NA | NA | NA | positive | |
| human leukocyte antigen-b*39:01, human leukocyte antigen-b*51:01, human leukocyte antigen-b*58:01 and human leukocyte antigen-c*03:02 were significantly associated with migraine, with age and sex-adjusted odds ratios (95% cis) of 1.80 (1.28-2.53), 1.50 (1.15-1.97), 1.36 (1.14-1.62) and 1.36 (1.14-1.62), correspondingly. | |||||||
| 31973566 | HLA-C*03 | migraine | NA | NA | NA | positive | |
| human leukocyte antigen-b*39:01, human leukocyte antigen-b*51:01, human leukocyte antigen-b*58:01 and human leukocyte antigen-c*03:02 were significantly associated with migraine, with age and sex-adjusted odds ratios (95% cis) of 1.80 (1.28-2.53), 1.50 (1.15-1.97), 1.36 (1.14-1.62) and 1.36 (1.14-1.62), correspondingly. | |||||||
| 31973566 | HLA-B*51 | migraine | NA | NA | NA | positive | |
| human leukocyte antigen-b*39:01, human leukocyte antigen-b*51:01, human leukocyte antigen-b*58:01 and human leukocyte antigen-c*03:02 were significantly associated with migraine, with age and sex-adjusted odds ratios (95% cis) of 1.80 (1.28-2.53), 1.50 (1.15-1.97), 1.36 (1.14-1.62) and 1.36 (1.14-1.62), correspondingly. | |||||||
| 31973566 | HLA-B*39 | migraine | NA | NA | NA | positive | |
| human leukocyte antigen-b*39:01, human leukocyte antigen-b*51:01, human leukocyte antigen-b*58:01 and human leukocyte antigen-c*03:02 were significantly associated with migraine, with age and sex-adjusted odds ratios (95% cis) of 1.80 (1.28-2.53), 1.50 (1.15-1.97), 1.36 (1.14-1.62) and 1.36 (1.14-1.62), correspondingly. | |||||||
| 20716448 | HLA (HLA) | meningiti | NA | epitopic | NA | unclassified | |
| in silico cd4+ t-cell epitope prediction and hla distribution analysis for the potential proteins of neisseria meningitidis serogroup b--a clue for vaccine development. | |||||||
| 9843183 | HLA-DR (HLA-DR) | thrombus | NA | NA | NA | unclassified | |
| in contrast, flow cytometry revealed that the expression of adhesion molecules (cd11a, cd11b, cd11, cd3, cd14, cd62l, hla-dr and binding of fibrinogen) on the surface of circulating leukocytes passing the thrombi was, on short term conditions (15 min), independent of thrombus growth. | |||||||
| 19703758 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | thrombus | NA | NA | NA | unclassified | |
| uptake of hbmms into the thrombus induced in these mice was confirmed by a combination of pkh2-labeled cell tracking and colocalization with human leukocyte antigen (hla) by immunohistology. | |||||||
Copyright 2024